1. Home
  2. LQDA vs BIRK Comparison

LQDA vs BIRK Comparison

Compare LQDA & BIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LQDA

Liquidia Corporation

HOLD

Current Price

$68.49

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

Logo Birkenstock Holding plc

BIRK

Birkenstock Holding plc

HOLD

Current Price

$33.53

Market Cap

5.6B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
LQDA
BIRK
Founded
2004
1774
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
5.6B
IPO Year
2020
2023

Fundamental Metrics

Financial Performance
Metric
LQDA
BIRK
Price
$68.49
$33.53
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
14
Target Price
$41.00
★ $61.43
AVG Volume (30 Days)
963.9K
★ 2.0M
Earning Date
05-08-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 51.81
N/A
EPS
★ 1.26
N/A
Revenue
★ $158,320,000.00
N/A
Revenue This Year
$278.87
$13.71
Revenue Next Year
$57.13
$14.30
P/E Ratio
$56.31
★ $17.48
Revenue Growth
★ 1031.18
N/A
52 Week Low
$21.35
$29.93
52 Week High
$93.61
$50.73

Technical Indicators

Market Signals
Indicator
LQDA
BIRK
Relative Strength Index (RSI) 47.51 51.00
Support Level $62.86 $33.06
Resistance Level $92.35 $37.29
Average True Range (ATR) 2.78 1.08
MACD 0.69 0.44
Stochastic Oscillator 66.74 80.36

Price Performance

Historical Comparison
LQDA
BIRK

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.

About BIRK Birkenstock Holding plc

Birkenstock is a German footwear brand known for comfort-focused, timeless designs, with 76% of 2022 sales coming from its top five iconic models. Products are made in Europe using sustainable, mostly locally sourced materials. The brand combines orthopedic function with everyday style, appealing to a broad audience. The Americas account for 52% of sales, EMEA 37%, with the remainder coming from Asia-Pacific, which has also the higher future growth expectations.

Share on Social Networks: